• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA CASC2 通过调控 miR-24-3p 抑制肝癌细胞的活力并诱导其凋亡。

LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.

机构信息

Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

出版信息

J Cell Biochem. 2018 Aug;119(8):6391-6397. doi: 10.1002/jcb.26479. Epub 2018 May 9.

DOI:10.1002/jcb.26479
PMID:29091305
Abstract

Cancer susceptibility candidate 2 (CASC2), a recently discovered long non-coding RNA (lncRNA), was confirmed to play numerous roles in several human cancers. However, the involvement and concrete mechanism of CASC2 in hepatocellular carcinoma (HCC) still need to be further elucidated. The relative expressions of CASC2 and miR-24-3p in HCC tissue and cell lines were determined by quantitative real-time PCR (qRT-PCR). The effects of CASC2 and miR-24-3p on HCC cells were further assessed via cell viability and apoptosis. In vivo tumorigenesis assay was performed to verify the inhibition effect of CASC2 on the tumor growth and further clarify the important role of miR-24-3p in this mechanism. Compared with the paired normal tissues, the relative expression of CASC2 significantly reduced in the HCC tissues, while miR-24-3p as determined by qRT-PCR obviously increased in the HCC tissues. This observation was also found in HCC cell lines. Meanwhile, the expression of CASC2 was negatively related to miR-24-3p expression in the HCC tissues (r = -0.804, P < 0.001). CASC2 could negatively regulate the expression of miR-24-3p in vitro. Moreover, CASC2 overexpression resulted in the growth inhibitory and apoptosis-inducing effects on HCC cells, but the up-regulation of miR-24-3p greatly eliminated the CASC2-induced effects. The tumorigenesis of HCC cells was restrained significantly by CASC2 overexpression as shown by decreased tumor volume and growth rate. However, miR-24-3p up-regulation rescued the inhibition of CASC2 on the tumor growth in tumor-bearing mice. LncRNA CASC2 inhibited the viability and induced the apoptosis of HCC cells through regulating miR-24-3p.

摘要

癌症易感性候选基因 2(CASC2)是一种新发现的长链非编码 RNA(lncRNA),已被证实参与多种人类癌症的发生。然而,CASC2 在肝细胞癌(HCC)中的作用及其具体机制仍需进一步阐明。采用实时定量 PCR(qRT-PCR)检测 HCC 组织和细胞系中 CASC2 和 miR-24-3p 的相对表达。通过细胞活力和凋亡进一步评估 CASC2 和 miR-24-3p 对 HCC 细胞的影响。进行体内肿瘤发生测定以验证 CASC2 对肿瘤生长的抑制作用,并进一步阐明 miR-24-3p 在该机制中的重要作用。与配对的正常组织相比,qRT-PCR 检测到 HCC 组织中 CASC2 的相对表达明显降低,而 miR-24-3p 的表达明显增加。在 HCC 细胞系中也观察到了这种情况。同时,HCC 组织中 CASC2 的表达与 miR-24-3p 的表达呈负相关(r=-0.804,P<0.001)。CASC2 可以在体外负调控 miR-24-3p 的表达。此外,CASC2 过表达对 HCC 细胞的生长抑制和凋亡诱导作用,但 miR-24-3p 的上调大大消除了 CASC2 诱导的作用。CASC2 过表达显著抑制 HCC 细胞的肿瘤发生,表现为肿瘤体积和生长速度降低。然而,miR-24-3p 的上调挽救了 CASC2 对荷瘤小鼠肿瘤生长的抑制作用。lncRNA CASC2 通过调节 miR-24-3p 抑制 HCC 细胞的活力并诱导其凋亡。

相似文献

1
LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.长链非编码 RNA CASC2 通过调控 miR-24-3p 抑制肝癌细胞的活力并诱导其凋亡。
J Cell Biochem. 2018 Aug;119(8):6391-6397. doi: 10.1002/jcb.26479. Epub 2018 May 9.
2
The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.长链非编码 RNA CASC2 通过直接下调 miR-183 抑制肝癌细胞的活力、迁移和侵袭。
Yonsei Med J. 2019 Oct;60(10):905-913. doi: 10.3349/ymj.2019.60.10.905.
3
Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.长链非编码 RNA CASC2 通过 CASC2/miR-367/FBXW7 轴抑制肝癌细胞的上皮-间充质转化。
Mol Cancer. 2017 Jul 17;16(1):123. doi: 10.1186/s12943-017-0702-z.
4
HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.HOXA-AS2通过miR-520c-3p/GPC3轴促进肝癌细胞增殖并诱导上皮-间质转化
Cell Physiol Biochem. 2018;50(6):2124-2138. doi: 10.1159/000495056. Epub 2018 Nov 9.
5
Long Non-Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression.长链非编码RNA MALAT1通过海绵吸附miR-143-3p调控ZEB1表达并促进肝细胞癌进展。
J Cell Biochem. 2017 Dec;118(12):4836-4843. doi: 10.1002/jcb.26158. Epub 2017 Jun 13.
6
LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.长链非编码 RNA DBH-AS1 通过 FAK/Src/ERK 通路靶向 miR-138 促进肝癌的发生。
Biomed Pharmacother. 2018 Nov;107:824-833. doi: 10.1016/j.biopha.2018.08.079. Epub 2018 Aug 22.
7
Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.长链非编码RNA ANRIL的敲低通过调节miR-122-5p的表达抑制肝癌细胞的增殖、转移和侵袭。
J Cancer Res Clin Oncol. 2018 Feb;144(2):205-214. doi: 10.1007/s00432-017-2543-y. Epub 2017 Nov 10.
8
Long noncoding RNA CASC2 regulates hepatocellular carcinoma cell oncogenesis through miR-362-5p/Nf-κB axis.长链非编码 RNA CASC2 通过 miR-362-5p/Nf-κB 轴调控肝癌细胞的癌发生。
J Cell Physiol. 2018 Oct;233(10):6661-6670. doi: 10.1002/jcp.26446. Epub 2018 Apr 17.
9
MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma.miR-450b-3p 通过靶向磷酸甘油酸激酶 1 抑制肝癌细胞生长。
J Cell Biochem. 2019 Nov;120(11):18805-18815. doi: 10.1002/jcb.29196. Epub 2019 Jun 21.
10
Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.长链非编码RNA NEAT1通过调控miR-129-5p-VCP-IκB促进肝癌细胞增殖。
Am J Physiol Gastrointest Liver Physiol. 2017 Aug 1;313(2):G150-G156. doi: 10.1152/ajpgi.00426.2016. Epub 2017 May 19.

引用本文的文献

1
CRISPR-based dissection of microRNA-23a ~ 27a ~ 24-2 cluster functionality in hepatocellular carcinoma.基于 CRISPR 的肝细胞癌中 microRNA-23a~27a~24-2 簇功能解析。
Oncogene. 2024 Aug;43(36):2708-2721. doi: 10.1038/s41388-024-03115-z. Epub 2024 Aug 7.
2
RPL9 acts as an oncogene by shuttling miRNAs through exosomes in human hepatocellular carcinoma cells.RPL9 通过将 miRNAs 穿梭到人类肝癌细胞的外泌体中而发挥癌基因的作用。
Int J Oncol. 2024 Jun;64(6). doi: 10.3892/ijo.2024.5646. Epub 2024 Apr 19.
3
POU6F1 promotes ferroptosis by increasing lncRNA-CASC2 transcription to regulate SOCS2/SLC7A11 signaling in gastric cancer.
POU6F1 通过增加 lncRNA-CASC2 的转录来促进铁死亡,从而调节胃癌中的 SOCS2/SLC7A11 信号通路。
Cell Biol Toxicol. 2024 Jan 25;40(1):3. doi: 10.1007/s10565-024-09843-y.
4
The expression and function of long noncoding RNAs in hepatocellular carcinoma.长链非编码RNA在肝细胞癌中的表达及功能
Cancer Innov. 2023 Aug 15;2(6):488-499. doi: 10.1002/cai2.90. eCollection 2023 Dec.
5
Long non-coding RNA CASC7 is a promising serum biomarker for hepatocellular carcinoma.长链非编码 RNA CASC7 是一种有前途的肝细胞癌血清标志物。
BMC Gastroenterol. 2023 Sep 21;23(1):324. doi: 10.1186/s12876-023-02961-7.
6
Evaluation of Plasma miR-17-5p, miR-24-3p and miRNA-223-3p Profile of Hepatitis C Virus-Infected Patients after Treatment with Direct-Acting Antivirals.直接作用抗病毒药物治疗后丙型肝炎病毒感染患者血浆miR-17-5p、miR-24-3p和miRNA-223-3p谱的评估
J Pers Med. 2023 Jul 26;13(8):1188. doi: 10.3390/jpm13081188.
7
The Long Noncoding RNA Cytoskeleton Regulator RNA (CYTOR)/miRNA-24-3p Axis Facilitates Nasopharyngeal Carcinoma Progression by Modulating GAD1 Expression.长链非编码RNA细胞骨架调节RNA(CYTOR)/微小RNA-24-3p轴通过调节GAD1表达促进鼻咽癌进展。
J Oncol. 2023 Feb 13;2023:6027860. doi: 10.1155/2023/6027860. eCollection 2023.
8
Long Non-Coding RNA Functions as A Tumor Suppressor in Colorectal Cancer via Modulating The Pathway.长链非编码RNA通过调节该通路在结直肠癌中发挥肿瘤抑制作用。
Cell J. 2022 Nov 2;24(11):665-672. doi: 10.22074/cellj.2022.8036.
9
The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression.长链非编码RNA在肿瘤发生和进展中对F-box蛋白调控的作用。
Front Oncol. 2022 Jul 19;12:963617. doi: 10.3389/fonc.2022.963617. eCollection 2022.
10
Long Noncoding RNA CASC2 Facilitated Wound Healing through miRNA-155/HIF-1 in Diabetic Foot Ulcers.长链非编码 RNA CASC2 通过 miRNA-155/HIF-1 促进糖尿病足溃疡愈合。
Contrast Media Mol Imaging. 2022 Jun 24;2022:6291497. doi: 10.1155/2022/6291497. eCollection 2022.